The nanovesicle was shown to covalently capture WT and Omicron RBDs, consistent with our data using ACE2 (E23FSY)‐Fc, and efficiently inhibited infection by WT and Omicron SARS‐CoV‐2, reducing animal mortality when used as an inhalable spray. This evidence concerns the gene ACE2 and infection.